Hormone receptor positive (ER+/PR+/HER2−) breast cancer (BCa), commonly known as estrogen receptor positive (ER+) breast cancer, represents approximately 65–70% of new breast cancer cases diagnosed each year and accounts for the highest number of breast cancer related deaths. This evidence concerns the gene NR4A1 and breast carcinoma.